Crossmark

Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival

Published Online: 2020-09-07

Published Print: 2020-12

Authors

Piqué, Daniel G.

Greally, John M.

Mar, Jessica C. https://orcid.org/0000-0002-5147-9299
Funding

Funding for this research was provided by:

National Institutes of Health (1R01AG057422-01A1, T32-GM007288)

Australian Research Council (FT170100047)

National Stem Cell Foundation of Australia (Metcalf Prize)
License Information

Text and Data Mining valid from 2020-09-07

Version of Record valid from 2020-09-07
More Information

Article History

Received: 1 January 2020

Accepted: 20 August 2020

First Online: 7 September 2020

Ethics approval and consent to participate

: No permissions were required to use any of the repository data as all data used was publicly available.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current